Literature DB >> 19343038

Malignant pleural mesothelioma cells resist anoikis as quiescent pluricellular aggregates.

J Daubriac1, J Fleury-Feith, L Kheuang, J Galipon, A Saint-Albin, A Renier, M Giovannini, F Galateau-Sallé, M-C Jaurand.   

Abstract

Pleural fluid accumulation is a frequent clinical observation in diffuse malignant pleural mesothelioma (MPM). The cytological analysis of pleural fluid often reveals the presence of free spheroid aggregates of malignant cells, giving rise to the question of the ability of non-adherent tumor cells to resist the loss of anchorage-induced apoptosis (termed as anoikis), and to develop new tumor foci in the pleural cavity. Here, we show that MPM cells cultured under non-adherent conditions form well-organized aggregates composed of viable cells, which progressively enter in G(0). Although the PI3K/Akt, ERK and SAPK/JNK signaling pathways are activated in adherent MPM cells, loss of anchorage results in the inactivation of these pathways. By comparison, we show that the non-tumoral mesothelial cells MeT-5A enter anoikis in an SAPK/JNK-, Bim- and caspase-9-dependent pathway. The survival of MPM cells can be reversed by activating SAPK/JNK with anisomycin, according to a Bim-dependent mitochondrial pathway. Finally, our findings show that impairment of cell aggregation activates SAPK/JNK and Bim and induces anoikis. Our results underline the importance of intercellular contacts in the anoikis resistance of MPM cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343038     DOI: 10.1038/cdd.2009.32

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  10 in total

1.  The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy.

Authors:  Xinran Xiang; Yen Phung; Mingqian Feng; Kunio Nagashima; Jingli Zhang; V Courtney Broaddus; Raffit Hassan; David Fitzgerald; Mitchell Ho
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

Review 2.  Non-neoplastic and neoplastic pleural endpoints following fiber exposure.

Authors:  V Courtney Broaddus; Jeffrey I Everitt; Brad Black; Agnes B Kane
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

3.  The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance.

Authors:  D Barbone; J A Ryan; N Kolhatkar; A D Chacko; D M Jablons; D J Sugarbaker; R Bueno; A G Letai; L M Coussens; D A Fennell; V C Broaddus
Journal:  Cell Death Dis       Date:  2011-06-23       Impact factor: 8.469

4.  Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma.

Authors:  Dario Barbone; Loes Van Dam; Carlo Follo; Puthen V Jithesh; Shu-Dong Zhang; William G Richards; Raphael Bueno; Dean A Fennell; V Courtney Broaddus
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

5.  Transcriptomic study of the mechanism of anoikis resistance in head and neck squamous carcinoma.

Authors:  Chen Guo; Ling-Feng Xu; Hui-Min Li; Wei Wang; Ji-Hua Guo; Meng-Qi Jia; Rong Jia; Jun Jia
Journal:  PeerJ       Date:  2019-05-23       Impact factor: 2.984

6.  The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma.

Authors:  Viktoria Laszlo; Zsuzsanna Valko; Judit Ozsvar; Ildiko Kovacs; Tamas Garay; Mir Alireza Hoda; Thomas Klikovits; Paul Stockhammer; Clemens Aigner; Marion Gröger; Walter Klepetko; Walter Berger; Michael Grusch; Jozsef Tovari; Irene C Waizenegger; Balazs Dome; Balazs Hegedus
Journal:  J Mol Med (Berl)       Date:  2018-12-11       Impact factor: 4.599

7.  Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression.

Authors:  Dario Barbone; Priscilla Cheung; Sailaja Battula; Sara Busacca; Steven G Gray; Daniel B Longley; Raphael Bueno; David J Sugarbaker; Dean A Fennell; V Courtney Broaddus
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

8.  Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors.

Authors:  N Echeverry; G Ziltener; D Barbone; W Weder; R A Stahel; V C Broaddus; E Felley-Bosco
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

Review 9.  The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models.

Authors:  Christophe Blanquart; Marie-Claude Jaurand; Didier Jean
Journal:  Front Oncol       Date:  2020-03-25       Impact factor: 6.244

10.  Arachidonic acid drives adaptive responses to chemotherapy-induced stress in malignant mesothelioma.

Authors:  Mario Cioce; Claudia Canino; Harvey Pass; Giovanni Blandino; Sabrina Strano; Vito Michele Fazio
Journal:  J Exp Clin Cancer Res       Date:  2021-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.